At his confirmation hearing last month to lead the Food and Drug Administration, Robert Califf was pressed by U.S. senators for his views on the opioid crisis, on tobacco and e-cigarette regulation, and on his relationship with pharmaceutical and tech companies.
Califf came prepared and, by all accounts, sailed through.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
